Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | 2C32H49NO9.H2O4S |
| Molecular Weight | 1281.544 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 28 / 28 |
| E/Z Centers | 2 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OS(O)(=O)=O.C\C=C(\C)C(=O)O[C@H]1CC[C@@]2(C)[C@@H]3CC[C@H]4[C@]5(O)C[C@H](O)[C@@]6(O)[C@@H](CN7C[C@@H](C)CC[C@H]7[C@@]6(C)O)[C@]5(O)C[C@]24O[C@]13O.C\C=C(\C)C(=O)O[C@H]8CC[C@@]9(C)[C@@H]%10CC[C@H]%11[C@]%12(O)C[C@H](O)[C@@]%13(O)[C@@H](CN%14C[C@@H](C)CC[C@H]%14[C@@]%13(C)O)[C@]%12(O)C[C@]9%11O[C@]8%10O
InChI
InChIKey=LVNNUOZILAFQRM-OERGDMKHSA-N
InChI=1S/2C32H49NO9.H2O4S/c2*1-6-18(3)25(35)41-24-11-12-26(4)19-8-9-20-28(37)13-23(34)31(39)21(29(28,38)16-30(20,26)42-32(19,24)40)15-33-14-17(2)7-10-22(33)27(31,5)36;1-5(2,3)4/h2*6,17,19-24,34,36-40H,7-16H2,1-5H3;(H2,1,2,3,4)/b2*18-6-;/t2*17-,19-,20-,21-,22-,23-,24-,26-,27+,28+,29+,30+,31-,32-;/m00./s1
| Molecular Formula | H2O4S |
| Molecular Weight | 98.078 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C32H49NO9 |
| Molecular Weight | 591.7328 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 14 / 14 |
| E/Z Centers | 1 |
| Optical Activity | UNSPECIFIED |
Cevadine, veratridine, and related lipophilic ceveratrum alkaloids cause activation of the voltage-sensitive Na+ channels of nerve, heart, and skeletal muscle cell membranes similar to pyrethrins. Both veratridine and cevadine alter the ion selectivity of Na+ channels and cause persistent activation. The receptor for these alkaloids has not been isolated, but experiments indicate it is distinct from that of pyrethrin. Structurally, veratridine and cevadine differ only in their acyl group. Cevadine has been used as an insecticide, acting as a paralytic agent with higher toxicity to insects than to mammals. It has been used to study Na+ channel blockers such as vincamine and vincanol by inducing Na+ channels in the presence and absence of the drugs being tested.
Approval Year
Sample Use Guides
In Vivo Use Guide
Curator's Comment: Rats: veratrine (0.6 mg/kg, s.c.) significantly increased the plasma concentration of corticosterone, an endogenous biomarker for anxiety, compared to vehicle. https://www.ncbi.nlm.nih.gov/pubmed/26099814
Mouse:LD50 = 300mg/kg; oral
Rat: LD50 = 980 mg/kg; oral
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3872554
Cevadine sensitivity of sartorius muscles incubated in glutamate Ringer was about five times greater than that of muscles incubated in normal Ringer. Therefore, even 0.005 mmol/l cevadine could induce depolarization and membrane potential oscillations.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:23:23 GMT 2025
by
admin
on
Mon Mar 31 22:23:23 GMT 2025
|
| Record UNII |
3TU82R4MEV
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
7770-31-2
Created by
admin on Mon Mar 31 22:23:23 GMT 2025 , Edited by admin on Mon Mar 31 22:23:23 GMT 2025
|
PRIMARY | |||
|
36572
Created by
admin on Mon Mar 31 22:23:23 GMT 2025 , Edited by admin on Mon Mar 31 22:23:23 GMT 2025
|
PRIMARY | |||
|
15585-38-3
Created by
admin on Mon Mar 31 22:23:23 GMT 2025 , Edited by admin on Mon Mar 31 22:23:23 GMT 2025
|
NO STRUCTURE GIVEN | |||
|
119057566
Created by
admin on Mon Mar 31 22:23:23 GMT 2025 , Edited by admin on Mon Mar 31 22:23:23 GMT 2025
|
PRIMARY | |||
|
3TU82R4MEV
Created by
admin on Mon Mar 31 22:23:23 GMT 2025 , Edited by admin on Mon Mar 31 22:23:23 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |